Market revenue in 2024 | USD 512.2 million |
Market revenue in 2030 | USD 964.9 million |
Growth rate | 11.1% (CAGR from 2025 to 2030) |
Largest segment | Outsource |
Fastest growing segment | Outsource |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | In-house, Outsource |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device regulatory affairs market will help companies and investors design strategic landscapes.
Outsource was the largest segment with a revenue share of 66.56% in 2024. Horizon Databook has segmented the India medical device regulatory affairs market based on in-house, outsource covering the revenue growth of each sub-segment from 2018 to 2030.
India is gradually adopting new technology in medical devices. Certain developments have been made in precision surgical tools for wound closure, obstetrics, orthopedics, neurosurgery, and plastic & reconstructive surgery. The COVID-19 pandemic has further propelled advancements, increasing the demand for automated analysis, precision testing, and shorter turnarounds.
The rise in the adoption of new technologies for medical devices in the country is expected to improve the demand among regulatory affairs players in the country for developing new devices. This is creating competition among market players in the country. Some major companies operating in the country are IQVIA, Inc., Freyr, Intertek Group plc., and Laboratory Corporation of America Holdings.
These companies are undertaking various strategic initiatives to strengthen their market presence in the country. For instance, in June 2023, IQVIA introduced IQVIA RIM Smart Labeling, a holistic labeling solution for the life sciences sector. This innovative approach enhances global label management using intelligence-driven techniques, ensuring efficiency and compliance. With IQVIA RIM Smart Labeling, life sciences firms can unify their regulatory label planning, tracking, and execution systems, streamlining their processes into a single, integrated workflow
Horizon Databook provides a detailed overview of country-level data and insights on the India medical device regulatory affairs market , including forecasts for subscribers. This country databook contains high-level insights into India medical device regulatory affairs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account